Arbutus Biopharma (ABUS) Preferred Shares (2017 - 2021)
Arbutus Biopharma (ABUS) posted Preferred Shares of $161.0 million for Q3 2021, up 3.26% sequentially from $155.9 million in Q2 2021, and up 10.04% YoY from $146.3 million in Q3 2020.
Arbutus Biopharma (ABUS) Preferred Shares (2017 - 2021) Analysis & Trends
Arbutus Biopharma has reported Preferred Shares for 5 years, with the latest figure at $161.0 million in Q3 2021.
- Quarterly Preferred Shares rose 10.04% year-over-year to $161.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $161.0 million (up 10.04% YoY) and the FY2020 annual result came in at $149.4 million, up 8.83% from the prior year.
- Preferred Shares grew to $161.0 million in Q3 2021 per ABUS's latest filing, from $155.9 million in the prior quarter.
- Over five years, Preferred Shares peaked at $161.0 million in Q3 2021 and troughed at $49.8 million in Q4 2017.
- A 5-year average of $132.5 million and a median of $135.8 million in 2019 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2018 and 2021: Preferred Shares soared 153.39% in 2018, then grew 8.81% in 2021.
- Over 5 years, Preferred Shares stood at $49.8 million in 2017, then jumped by 153.39% to $126.1 million in 2018, then gained by 8.84% to $137.3 million in 2019, then gained by 8.83% to $149.4 million in 2020, then advanced by 7.74% to $161.0 million in 2021.
- According to Business Quant data, Preferred Shares over the past three periods registered $161.0 million, $155.9 million, and $152.6 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 160.97 Mn |
| Jun 30, 2021 | 155.89 Mn |
| Mar 31, 2021 | 152.62 Mn |
| Dec 31, 2020 | 149.41 Mn |
| Sep 30, 2020 | 146.29 Mn |
| Jun 30, 2020 | 143.26 Mn |
| Mar 31, 2020 | 140.26 Mn |
| Dec 31, 2019 | 137.29 Mn |
| Sep 30, 2019 | 134.41 Mn |
| Jun 30, 2019 | 131.61 Mn |
| Mar 31, 2019 | 128.85 Mn |
| Dec 31, 2018 | 126.14 Mn |
| Sep 30, 2018 | 123.49 Mn |
| Jun 30, 2018 | 120.92 Mn |
| Mar 31, 2018 | 118.38 Mn |
| Dec 31, 2017 | 49.78 Mn |